Latest Overactive Bladder News
Increased facility use of mesh augmentation impacts risk of repeat prolapse repair surgery
Correlates of receiving prescription include female sex, specific physician specialty, geographic region
Desmopressin orally disintegrating tablets resulted in declines in nocturnal voids in men and women with nocturnal polyuria and mild daytime voiding dysfunction.
In a study, 28% of all incident in-hospital falls were associated with nighttime visits to the toilet.
In a study, nocturnal polyuria was present in 30% of women with overactive bladder.
Taking 2 or more drugs for hypertension is associated with a significantly higher number of nocturnal voids and higher nocturnal polyuria index, study finds.
Phase 4 trial showed that mirabegron significantly decreased incontinence episodes and micturitions compared with placebo among patients aged 65 years and older.
A study of commercially insured patients showed Asians and Hispanics were less likely than whites to undergo advanced overactive bladder treatments.
Study suggests male OAB could be associated with abnormalities in metabolic pathways of fatty acids and bile acids.
Even modestly elevated fasting plasma glucose levels and HbA1c is associated with increased odds of overactive bladder.
The ratio of visceral fat volume to total abdominal fat volume is an independent risk factor for overactive bladder, study finds.
German study revealed a 13% higher risk of falls among patients with vs without nocturia.
Of patients who had transient stress urinary incontinence after holmium laser enucleation of the prostate, 88.6% experienced resolution of the incontinence within 6 weeks after the procedure.
An expert panel developed a framework of 22 nocturia phenotypes that could set the stage for devising diagnostic and treatment pathways and stimulating research.
Among patients with detrusor underactivity, 14% of women had neuropathic causes compared with only 2% of men.
Renal and Urology News Articles
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)